Figure 2b: Achieving HIV-1 RNA < 50 copies/mL – ITT. The proportion of subjects achieving an HIV-1 RNA <50 copies/mL at each study visit. Subjects with baseline HIV-1 RNA > 100.000 copies /mL (left-hand panel) or < 100.000 copies/mL (right-hand panel). ITT, Intention-to treat analysis; LPV/r, Lopinavir/ritonavir; NRTI, Nucleoside Reverse Transcriptase Inhibitor; TDF, Tenofovir Disoproxyl Fumarate; BL, Baseline, W, treatment week.